Diffuse Cerebral Sclerosis of Schilder: Clinical Trials

3 trials for Diffuse Cerebral Sclerosis of Schilder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 21Terminated 1

Follow Diffuse Cerebral Sclerosis of Schilder: new trials by email Literature Review of Diffuse Cerebral Sclerosis of Schilder trials Research Report on Diffuse Cerebral Sclerosis of Schilder

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease
Vatiquinone - Inherited Mitochondrial Disease
Phase 3CompletedPTC Therapeutics1012022-06-222025-12-22
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Vatiquinone, Placebo - Mitochondrial Diseases, Drug Resistant Epilepsy
Phase 2 / Phase 3TerminatedPTC Therapeutics682020-09-282026-03-31
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Plasma exchange - Acute Disseminated Encephalomyelitis, Devic's Syndrome
Phase 3UnknownNational Institute of Neurological Disorders and Stroke (NINDS)221995-01-012005-06-24

Narrower conditions

Drug Resistant Epilepsy (2)  ·  Leigh Disease (2)  ·  MELAS Syndrome (2)  ·  MERRF Syndrome (2)  ·  Encephalomyelitis, Acute Disseminated (1)  ·  Mental Disorders (1)  ·  Mitochondrial Diseases (1)  ·  Mitochondrial Encephalomyopathies (1)  ·  Mitochondrial encephalopathy (1)  ·  Multiple Sclerosis (1)  ·  Myelitis, Transverse (1)  ·  Nerve Degeneration (1)  ·  Neurologic Manifestations (1)  ·  Neuromyelitis Optica (1)

Broader conditions

Autoimmune Diseases (3)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Demyelinating Autoimmune Diseases, CNS (3)  ·  Demyelinating Diseases (3)  ·  Immune System Diseases (3)  ·  Leukoencephalopathies (3)  ·  Nervous System Diseases (3)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Cardiovascular Diseases (2)  ·  Cerebral Small Vessel Diseases (2)  ·  Cerebrovascular Disorders (2)

Interventions

alpha-tocotrienol quinone (2)  ·  Plasma Exchange (1)

Sponsors

PTC Therapeutics (2)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)

Countries

France (2)  ·  Italy (2)  ·  Japan (2)  ·  Poland (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Canada (1)  ·  Sweden (1)

Top investigators

Vinay Penematsa, MD (2)  ·  Brian G. Weinshenker (1)